go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Nevada rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $562,341 · 10th–90th $478,630$1,412,5380%20%40%10th90th$562,341Professionalmedian $562,341 · 10th–90th $562,341$645,6540%50%90th$562,341$0.1$1.0$20.0$500.0$10.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$891,250.94
Typical High
$2,398,832.92
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$616,595.00
Anthem BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.03
Median
$0.03
Typical High
$0.03
Anthem BCBS
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
Cigna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
Hometown Health
Setting
Professional
Modifier
Global
Typical Low
$575,439.94
Median
$575,439.94
Typical High
$676,082.98
Select Health
Setting
Facility
Modifier
Global
Typical Low
$478,630.09
Median
$501,187.23
Typical High
$562,341.33
Select Health
Setting
Professional
Modifier
Global
Typical Low
$501,187.23
Median
$562,341.33
Typical High
$588,843.66
United
Setting
Professional
Modifier
Global
Typical Low
$512,861.38
Median
$676,082.98
Typical High
$870,963.59